Clinical Trials Browser

INDUSTRY × Non Small Cell Lung Cancer NSCLC × 1 year × Clear all

NCT03164616 2026-03-13

POSEIDON

Phase 3 Active not recruiting

1,186 enrolled 26 charts 2 FDA

Non Small Cell Lung Cancer NSCLC

NCT07169708 2025-09-12

A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)

Not yet recruiting

Non Small Cell Lung Cancer NSCLC